Alimera Sciences to Report First Quarter 2023 Financial Results on May 15, 2023, and Provide Corporate Update

Rhea-AI Summary

Alimera Sciences, Inc. will report first quarter financial results on May 15, 2023, and host a conference call to review financial results and provide corporate updates.

Positive

• Alimera Sciences will report its first quarter financial results on May 15, 2023, which could positively impact investor sentiment and potentially lead to increased stock price.

Negative

• No negative takes available.

Conference Call to be held the same day at 9:00am Eastern Time

ATLANTA, May 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report first quarter financial results on May 15, 2023, prior to the market open.

Management will host a conference call at 9:00 AM ET on the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.

Participants are asked to pre-register for the call.

Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

The conference call will also be available through a live webcast, which is also available through the company’s website.

A webcast replay of the call will be available approximately one hour after the end of the call through May 29, 2023. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 5487002. The telephonic replay will be available until August 29, 2023.

About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:	For investor inquiries:
Jules Abraham	Scott Gordon
for Alimera Sciences	for Alimera Sciences
917-885-7378	scottg@coreir.com
julesa@coreir.com

FAQ

When will Alimera Sciences report its first quarter financial results?

Alimera Sciences will report its first quarter financial results on May 15, 2023.

What can investors expect from the conference call?

Investors can expect a review of financial results and updates on corporate developments during the conference call.

How can participants join the conference call?

Participants can pre-register for the call to receive their dial-in number, or dial in directly using the provided numbers. Internet access is also available for a live webcast of the call.

Will there be a replay of the conference call?

Yes, a webcast replay of the call will be available through the company's website and a telephonic replay can be accessed using the provided numbers.